SCHEMBL5628091

SCHEMBL5628091

CN1CCC(CN2CC(C)(C)c3cc[c]cc32)CC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
ACHE P22303 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6245979 0.89 ACHE (0.36) ACHE
SCHEMBL5627064 0.85 DRD2 (0.32)
SCHEMBL428104 0.78 OPRD1 (0.41) ACHE
SCHEMBL5626006 0.77 CHRM2 (0.36)
SCHEMBL448065 0.77 OPRD1 (0.40)
SCHEMBL5626839 0.76 NOTUM (0.35)
SCHEMBL1451614 0.75 NOTUM (0.36)
SCHEMBL4102749 0.73 ACHE (0.47) CYP1A2CYP2D6ACHE
SCHEMBL1450529 0.73 KDM4E (0.36) CYP1A2CYP2D6
SCHEMBL1450311 0.73 SIGMAR1 (0.33) CYP1A2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7307088-B2 Substituted anthranilic amide derivatives and methods of use AMGEN INC. (US) 2007-12-11 US disclosed
EP-1519921-A2 SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2005-04-06 EP disclosed
WO-2004005279-A2 SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2004-01-15 WO disclosed